News

HealthDay on MSN16m
Vinay Prasad Returns to FDA After Being Ousted
Key Takeaways Vinay Prasad is returning as head of the FDA’s Center for Biologics Evaluation and ResearchHe was reportedly ...
STAT45s
That was fast: Vinay Prasad is back at CBER
Today, we discuss lots of government maneuvering that impacts biopharma — starting, of course, with the FDA reinstating Vinay ...
The Pharma Letter18m
Handbrake turn at FDA as Vinay Prasad returns to CBER
Vinay Prasad has returned to lead the US regulator’s Center for Biologics Evaluation and Research, resuming responsibility ...
Vinay Prasad’s Return to FDA Sends Biotech Shares Tumbling
The shares of biotech companies fell after news that ousted regulator Vinay Prasad is set to go back to the US Food and Drug Administration.Prasad had previously overruled his own scientific review ...
MedPage Today33m
Soap Recall Over Sepsis Risk; FDA Rehires Vinay Prasad; NIH Reports Patient to ICE
Note that some links may require registration or subscription. DermaRite Industries is recalling certain lots of its over-the ...
STAT40m
Pharmalittle: We’re reading about Prasad’s return to FDA, a journal sparring with RFK Jr., and more
Plus more pharma news from the Pharmalittle newsletter.
The CDC shooting aftermath
CDC employees across all of the agency’s campuses will be teleworking today, after a gunman shot multiple rounds into four ...
America’s drug regulator is in turmoil
Laura Loomer, a conspiracy theorist with access to President Donald Trump, accused Vinay Prasad—Dr Marks’ successor and a long-standing critic of loosening evidentiary standards for drug approvals—of ...